Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.36 +1.19%
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.59
Today's EPS Names:
CRMT, More
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.59
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Trifecta Gold closes $1.66M private placement for Yukon exploration
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
